檢索結果 - Michael Naughton

Refine Results
  1. 1
    Is rapid scientific publication also high quality? Bibliometric analysis of highly disseminated <scp>COVID</scp>‐19 research papers

    Is rapid scientific publication also high quality? Bibliometric analysis of highly disseminated <scp>COVID</scp>‐19 research papers 由 Amandeep Khatter, Michael Naughton, Hajira Dambha‐Miller, Patrick Redmond

    出版 2021
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  2. 2
    Association of PET-based estradiol-challenge test for breast cancer progesterone receptors with response to endocrine therapy

    Association of PET-based estradiol-challenge test for breast cancer progesterone receptors with response to endocrine therapy 由 Farrokh Dehdashti, Ningying Wu, X. Cynthia, Michael Naughton, John A. Katzenellenbogen, Barry A. Siegel

    出版 2021
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  3. 3
    Mammaglobin-A cDNA vaccination of breast cancer patients induces antigen-specific cytotoxic CD4+ICOShi T cells

    Mammaglobin-A cDNA vaccination of breast cancer patients induces antigen-specific cytotoxic CD4+ICOShi T cells 由 Venkataswarup Tiriveedhi, Timothy P. Fleming, Peter S. Goedegebuure, Michael Naughton, X. Cynthia, Craig Lockhart, Feng Gao, William E. Gillanders, T. Mohanakumar

    出版 2012
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  4. 4
    Prevalence of mental illness among parents of children receiving treatment within child and adolescent mental health services (CAMHS): a scoping review

    Prevalence of mental illness among parents of children receiving treatment within child and adolescent mental health services (CAMHS): a scoping review 由 Timothy Colin Heath Campbell, Andrea Reupert, Keith Sutton, Soumya Basu, Gavin Davidson, Christel M. Middeldorp, Michael Naughton, Darryl Maybery

    出版 2020
    獲取全文
    Revisão
    加到收藏夾
    Saved in:
  5. 5
    PET-based estradiol challenge as a predictive biomarker of response to endocrine therapy in women with estrogen-receptor-positive breast cancer

    PET-based estradiol challenge as a predictive biomarker of response to endocrine therapy in women with estrogen-receptor-positive breast cancer 由 Farrokh Dehdashti, Joanne Mortimer, Kathryn Trinkaus, Michael Naughton, Matthew J. Ellis, John A. Katzenellenbogen, Michael J. Welch, Barry A. Siegel

    出版 2008
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  6. 6
    Discussing Bad News in the Outpatient Oncology Clinic: Rethinking Current Communication Guidelines

    Discussing Bad News in the Outpatient Oncology Clinic: Rethinking Current Communication Guidelines 由 Susan Eggly, Louis A. Penner, Terrance L. Albrecht, Rebecca J. Cline, Tanina Foster, Michael Naughton, Amy M. Peterson, John C. Ruckdeschel

    出版 2006
    獲取全文 獲取全文
    Revisão
    加到收藏夾
    Saved in:
  7. 7
    Isolation and Molecular Profiling of Bone Marrow Micrometastases Identifies <i>TWIST1</i> as a Marker of Early Tumor Relapse in Breast Cancer Patients

    Isolation and Molecular Profiling of Bone Marrow Micrometastases Identifies <i>TWIST1</i> as a Marker of Early Tumor Relapse in Breast Cancer Patients 由 Mark A. Watson, Lourdes R. Ylagan, Kathryn Trinkaus, William E. Gillanders, Michael Naughton, Katherine N. Weilbaecher, Timothy P. Fleming, Rebecca Aft

    出版 2007
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  8. 8
    Phase I Study of Everolimus Plus Weekly Paclitaxel and Trastuzumab in Patients With Metastatic Breast Cancer Pretreated With Trastuzumab

    Phase I Study of Everolimus Plus Weekly Paclitaxel and Trastuzumab in Patients With Metastatic Breast Cancer Pretreated With Trastuzumab 由 Fabrice André, Mario Campone, Ruth O’Regan, C. Manlius, Cristian Massacesi, Sahmoud Tarek, Pabak Mukhopadhyay, Jean‐Charles Soria, Michael Naughton, Sara A. Hurvitz

    出版 2010
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  9. 9
    Evaluation of [89Zr]trastuzumab-PET/CT in differentiating HER2-positive from HER2-negative breast cancer

    Evaluation of [89Zr]trastuzumab-PET/CT in differentiating HER2-positive from HER2-negative breast cancer 由 Farrokh Dehdashti, Ningying Wu, Ron Bose, Michael Naughton, X. Cynthia, Bernadette Marquez‐Nostra, Philipp Diebolder, Cedric Mpoy, Buck E. Rogers, Suzanne E. Lapi, Richard Laforest, Barry A. Siegel

    出版 2018
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  10. 10
    A molecular-imprint nanosensor for ultrasensitive detection of proteins

    A molecular-imprint nanosensor for ultrasensitive detection of proteins 由 Dong Cai, Lu Ren, Huaizhou Zhao, Chenjia Xu, Lu Zhang, Ying Yu, Dandan Wang, Yucheng Lan, Mary F. Roberts, Jeffrey H. Chuang, Michael Naughton, Zhifeng Ren, Thomas C. Chiles

    出版 2010
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  11. 11
    Pneumolysin Activates Macrophage Lysosomal Membrane Permeabilization and Executes Apoptosis by Distinct Mechanisms without Membrane Pore Formation

    Pneumolysin Activates Macrophage Lysosomal Membrane Permeabilization and Executes Apoptosis by Distinct Mechanisms without Membrane Pore Formation 由 Martin A. Bewley, Michael Naughton, Julie A. Preston, Andrea M. Mitchell, Ashleigh Holmes, Helen M. Marriott, Robert C. Read, Timothy J. Mitchell, Moira K. B. Whyte, David H. Dockrell

    出版 2014
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  12. 12
    A Phase I Study of the AKT Inhibitor MK-2206 in Combination with Hormonal Therapy in Postmenopausal Women with Estrogen Receptor–Positive Metastatic Breast Cancer

    A Phase I Study of the AKT Inhibitor MK-2206 in Combination with Hormonal Therapy in Postmenopausal Women with Estrogen Receptor–Positive Metastatic Breast Cancer 由 X. Cynthia, César Sánchez, Feng Gao, Robert J. Crowder, Michael Naughton, Timothy Pluard, Allison Creekmore, Zhanfang Guo, Jeremy Hoog, A. Craig Lockhart, Austin Doyle, Charles Erlichman, Matthew J. Ellis

    出版 2016
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  13. 13
    Quality of life outcomes from the Exercise and Nutrition Enhance Recovery and Good Health for You (ENERGY)-randomized weight loss trial among breast cancer survivors

    Quality of life outcomes from the Exercise and Nutrition Enhance Recovery and Good Health for You (ENERGY)-randomized weight loss trial among breast cancer survivors 由 Wendy Demark‐Wahnefried, Graham A. Colditz, Cheryl L. Rock, Rebecca L. Sedjo, Jingxia Liu, Kathleen Y. Wolin, Helen Krontiras, Tim Byers, Bilgé Pakiz, Barbara A. Parker, Michael Naughton, Anthony Elias, Patricia A. Ganz

    出版 2015
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  14. 14
    Phase II trial of temsirolimus in patients with metastatic breast cancer

    Phase II trial of temsirolimus in patients with metastatic breast cancer 由 Gini F. Fleming, X. Cynthia, Dezheng Huo, Husain Sattar, Maria Tretiakova, Lin Li, Olwen Hahn, F. O. Olopade, Rachita Nanda, Philip C. Hoffman, Michael Naughton, Timothy Pluard, Suzanne D. Conzen, Matthew J. Ellis

    出版 2012
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  15. 15
    Safety and Preliminary Evidence of Biologic Efficacy of a Mammaglobin-A DNA Vaccine in Patients with Stable Metastatic Breast Cancer

    Safety and Preliminary Evidence of Biologic Efficacy of a Mammaglobin-A DNA Vaccine in Patients with Stable Metastatic Breast Cancer 由 Venkataswarup Tiriveedhi, Natalia Tucker, John M. Herndon, Lijin Li, Mark Sturmoski, Matthew J. Ellis, X. Cynthia, Michael Naughton, A. Craig Lockhart, Feng Gao, Timothy P. Fleming, Peter S. Goedegebuure, Thalachallour Mohanakumar, William E. Gillanders

    出版 2014
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  16. 16
    Randomized Phase III Trial of Paclitaxel Once Per Week Compared With Nanoparticle Albumin-Bound Nab-Paclitaxel Once Per Week or Ixabepilone With Bevacizumab As First-Line Chemotherapy for Locally Recurrent or Metastatic Breast Cancer: CALGB 40502/NCCTG N063H (Alliance)

    Randomized Phase III Trial of Paclitaxel Once Per Week Compared With Nanoparticle Albumin-Bound Nab-Paclitaxel Once Per Week or Ixabepilone With Bevacizumab As First-Line Chemother... 由 Hope S. Rugo, William T. Barry, Alvaro Moreno‐Aspitia, Alan P. Lyss, Constance Cirrincione, Eleanor H. Leung, Erica L. Mayer, Michael Naughton, Deborah Toppmeyer, Lisa A. Carey, Edith A. Perez, Clifford A. Hudis, Eric P. Winer

    出版 2015
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  17. 17
    Reducing breast cancer recurrence with weight loss, a vanguard trial: The Exercise and Nutrition to Enhance Recovery and Good Health for You (ENERGY) Trial

    Reducing breast cancer recurrence with weight loss, a vanguard trial: The Exercise and Nutrition to Enhance Recovery and Good Health for You (ENERGY) Trial 由 Cheryl L. Rock, Tim Byers, Graham A. Colditz, Wendy Demark‐Wahnefried, Patricia A. Ganz, Kathleen Y. Wolin, Anthony Elias, Helen Krontiras, Jingxia Liu, Michael Naughton, Bilgé Pakiz, Barbara A. Parker, Rebecca L. Sedjo, Holly R. Wyatt

    出版 2012
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  18. 18
    Results of the Exercise and Nutrition to Enhance Recovery and Good Health for You (ENERGY) Trial: A Behavioral Weight Loss Intervention in Overweight or Obese Breast Cancer Survivors

    Results of the Exercise and Nutrition to Enhance Recovery and Good Health for You (ENERGY) Trial: A Behavioral Weight Loss Intervention in Overweight or Obese Breast Cancer Survivo... 由 Cheryl L. Rock, Shirley W. Flatt, Tim Byers, Graham A. Colditz, Wendy Demark‐Wahnefried, Patricia A. Ganz, Kathleen Y. Wolin, Anthony Elias, Helen Krontiras, Jingxia Liu, Michael Naughton, Bilgé Pakiz, Barbara A. Parker, Rebecca L. Sedjo, Holly R. Wyatt

    出版 2015
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  19. 19
    Breast Cancer Adjuvant Chemotherapy Decisions in Older Women: The Role of Patient Preference and Interactions With Physicians

    Breast Cancer Adjuvant Chemotherapy Decisions in Older Women: The Role of Patient Preference and Interactions With Physicians 由 Jeanne S. Mandelblatt, Vanessa B. Sheppard, Arti Hurria, Gretchen Kimmick, Claudine Isaacs, Kathryn L. Taylor, Alice B. Kornblith, Anne‐Michelle Noone, George Luta, Michelle Tallarico, William T. Barry, Lisa Hunegs, Robin Zoň, Michael Naughton, Eric P. Winer, Clifford A. Hudis, Stephen B. Edge, Harvey Jay Cohen, Hyman B. Muss

    出版 2010
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  20. 20
    A Phase I Study with Neratinib (HKI-272), an Irreversible Pan ErbB Receptor Tyrosine Kinase Inhibitor, in Patients with Solid Tumors

    A Phase I Study with Neratinib (HKI-272), an Irreversible Pan ErbB Receptor Tyrosine Kinase Inhibitor, in Patients with Solid Tumors 由 Kwok-K. Wong, Paula M. Fracasso, Ronald M. Bukowski, Thomas J. Lynch, Pamela N. Münster, Geoffrey I. Shapiro, Pasi A. Jänne, Joseph P. Eder, Michael Naughton, Matthew J. Ellis, Suzanne F. Jones, Tarek Mekhail, Charles Zacharchuk, Jennifer Vermette, Richat Abbas, Susan Quinn, Christine Powell, Howard A. Burris

    出版 2009
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:

檢索工具: